Blog Posts

Qatar Biobank, a member of Qatar Foundation, staff have successfully achieved the re-accreditation of the CAP certificate for two new years, starting from 2022. This

Blood cancers such as acute myeloid leukaemia (AML), multiple myeloma (MM), and chronic lymphoid leukaemia (CLL) are very rare and complex diseases. They vary greatly between patients and are

CHA Medical & Bio Group has begun construction on its cell gene biobank (CGB), housing a variety of high-tech pharmaceutical treatments, manufacturing, and research facilities

Qatar Biobank is conducting two separate studies on the impact of COVID-19 infection and the effect of the vaccines. Data and samples are collected from

The Swedish government decides on a legal council referral where it is proposed that the current Biobanks Act from 2003 be replaced by new legislation. The new

Characterizing the experience and impact of the COVID-19 pandemic among various populations remain challenging due to the limitations inherent in common data sources such as

We are happy to announce the release of OpenSpecimen v9.0. This release includes new features, usability enhancements, and bug fixes requested by customers. Release highlights:

Biobanking and assisted reproduction could become a reality for koalas by leveraging the existing technology used to help humans conceive. A detailed model, published today in the

Professor of Behavioural Neuroscience Martien Kas of the University of Groningen has recently started a research study on mental health and social behavior as part

Banking primary prostate cancer is challenging because the tumors are often difficult to visualize in the gross specimens and are frequently multifocal. However, biobanking tissue of

    By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

    The 'OpenSpecimen Biobanking LIMS RFP Q&A' Excel is emailed to you.
    Feel free to Contact Us for any questions.

    Srikanth Adiga,
    C.E.0, OpenSpecimen
    Email: sri@krishagni.com


      Avoid Gmail, Yahoo, etc. please.

      By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.

        The Features PDF has been emailed to you.
        Feel free to "Schedule a Demo" or "Contact Us" for any questions.

        Srikanth Adiga,
        C.E.0, OpenSpecimen
        Email: sri@krishagni.com

          By submitting to this form, I confirm that I have read and agree to Krishagni's Privacy Policy.